NO20010119L - Preparater omfattende GABA-analoger og kaffein - Google Patents

Preparater omfattende GABA-analoger og kaffein

Info

Publication number
NO20010119L
NO20010119L NO20010119A NO20010119A NO20010119L NO 20010119 L NO20010119 L NO 20010119L NO 20010119 A NO20010119 A NO 20010119A NO 20010119 A NO20010119 A NO 20010119A NO 20010119 L NO20010119 L NO 20010119L
Authority
NO
Norway
Prior art keywords
caffeine
preparations
gaba analogues
gaba
analogues
Prior art date
Application number
NO20010119A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010119D0 (no
Inventor
Leslie Magnus-Miller
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20010119D0 publication Critical patent/NO20010119D0/no
Publication of NO20010119L publication Critical patent/NO20010119L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010119A 1998-07-09 2001-01-08 Preparater omfattende GABA-analoger og kaffein NO20010119L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9213198P 1998-07-09 1998-07-09
PCT/US1999/013670 WO2000002562A1 (en) 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine

Publications (2)

Publication Number Publication Date
NO20010119D0 NO20010119D0 (no) 2001-01-08
NO20010119L true NO20010119L (no) 2001-01-08

Family

ID=22231777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010119A NO20010119L (no) 1998-07-09 2001-01-08 Preparater omfattende GABA-analoger og kaffein

Country Status (13)

Country Link
US (1) US6326374B1 (pt)
EP (1) EP1094817A1 (pt)
JP (1) JP2002520286A (pt)
KR (1) KR20010071777A (pt)
AU (1) AU772156B2 (pt)
BR (1) BR9911917A (pt)
CA (1) CA2332915C (pt)
ID (1) ID28277A (pt)
NO (1) NO20010119L (pt)
NZ (1) NZ508490A (pt)
PL (1) PL345340A1 (pt)
WO (1) WO2000002562A1 (pt)
ZA (1) ZA200007168B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003167A1 (en) 1996-07-24 1998-01-29 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
DK1169060T3 (da) * 1999-04-09 2006-01-16 Euro Celtique Sa Natriumkanalblokkerpræparater og anvendelse deraf
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
MXPA04002009A (es) 2001-09-03 2004-07-08 Newron Pharm Spa Composicion farmaceutica que comprende gabapentina o un analogo de la misma y alfa-aminoamida y su uso como analgesico.
ATE371496T1 (de) * 2004-03-12 2007-09-15 Warner Lambert Co C1-symmetrische bisphosphinliganden und deren verwendung bei der asymmetrischen synthese von pregabalin
JP2007530657A (ja) * 2004-04-01 2007-11-01 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Ｐキラル性ホスホランの調製および不斉合成でのその使用
DE602005018965D1 (de) * 2004-06-21 2010-03-04 Warner Lambert Co Herstellung von pregabalin und verwandten verbindungen
KR101277520B1 (ko) * 2004-09-10 2013-06-21 뉴론 파마슈티칼즈 에스. 피. 에이. （할로벤질옥시）벤질아미노－프로판아미드를 포함하는 선택적 나트륨 및／또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
ES2556937T3 (es) 2005-12-22 2016-01-21 Newron Pharmaceuticals S.P.A. Derivados de 2-feniletilamino como moduladores de los canales de calcio y/o sodio
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
CH699327B1 (de) 2007-02-14 2010-03-15 Oerlikon Heberlein Temco Wattw Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden.
US10300031B2 (en) 2007-08-06 2019-05-28 Trinity Laboratories Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
JP2010043063A (ja) * 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
US20100190752A1 (en) * 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656177A (en) 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US5248678A (en) * 1992-06-30 1993-09-28 Fractal Laboratories, Inc. Methods for increasing arousal and alertness and for the amelioration of comatose states
AU7604194A (en) 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
US5443838A (en) 1993-09-15 1995-08-22 Koenig, Jr.; Steven M. Nutritional supplementation system
ES2167717T3 (es) 1996-03-14 2002-05-16 Warner Lambert Co Nuevos aminoacidos ciclicos sustituidos como agentes farmaceuticos.
AU4078897A (en) * 1996-08-23 1998-03-06 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
ATE361909T1 (de) * 1996-10-23 2007-06-15 Warner Lambert Co Substituierte gamma-aminobuttersäurederivate als arzneimittel
ATE311867T1 (de) * 1997-09-08 2005-12-15 Warner Lambert Co Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen

Also Published As

Publication number Publication date
AU772156B2 (en) 2004-04-08
BR9911917A (pt) 2001-03-27
EP1094817A1 (en) 2001-05-02
CA2332915C (en) 2006-10-24
JP2002520286A (ja) 2002-07-09
US6326374B1 (en) 2001-12-04
WO2000002562A1 (en) 2000-01-20
NZ508490A (en) 2003-08-29
CA2332915A1 (en) 2000-01-20
ID28277A (id) 2001-05-10
ZA200007168B (en) 2002-03-04
NO20010119D0 (no) 2001-01-08
PL345340A1 (en) 2001-12-17
AU4691099A (en) 2000-02-01
KR20010071777A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
IS5744A (is) Nýjar 3-arýl-própíónsýruafleiður og -hliðstæður
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO20000700D0 (no) Interleukin-18-proteiner samt fremstilling og anvendelse derav
NO20032753L (no) Forbindelse og anvendelse derav
NO972911D0 (no) Stabiliserte ribozym-analoger
DE69826944D1 (de) Konsensus-Phytasen
NO20010119D0 (no) Preparater omfattende GABA-analoger og kaffein
NO991150D0 (no) Pyrazolopyrimidiner og pyrazolotriaziner
ITMI982280A0 (it) Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono
DE69823830D1 (de) Dermatologische zubereitungen
NO995683D0 (no) Vitamin D analoger og deres neuronale effekter
NO20000057L (no) Kjernerør
NO993731D0 (no) Pyrrolopyrazolopyrimidin-forbindelse og medisin omfattende denne
ITTV970086A0 (it) Struttura di pattino
ZA981419B (en) Arylsulfonamides and analogues
DK0826679T3 (da) Naphthylforbindelser og -præparater
DK0929577T3 (da) Stabiliserede proteinholdige protease-inhibitorer og varianter deraf
EE04701B1 (et) Kihisevad preparaadid
DE69806784T2 (de) Spieldose
FI974044A0 (fi) Spis
NO983556L (no) Formulering og anvendelse
DE69716042D1 (de) Magnetometer
DE69926005D1 (de) Carbamat- und carbazatketolidantibiotika
KR970049913U (ko) 연결관 조임구